Collectively, these results suggest that PCYT2 inhibits the metastasis of CRC in vitro, and the inhibitory effect of PCYT2 on the metastasis of CRC cells in vitro is mediated by its cytidine transferase domain. Here, PCYT2 is linked to colorectal carcinoma.